Neurones

Neurones Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Neurones (NRO.PA) as of Nov 22, 2026 is -28.19. In the previous year, Cash Conversion Cycle (CCC) was 29.80 — a change of -194.60% (lower).

Cash Conversion Cycle

-28.19

YoY

-194.60%

Last updated:

Cash Conversion Cycle (CCC) of Neurones is 2025 -28.19 . Cash Conversion Cycle (CCC) of Neurones was 2024 29.80 . It decreases by -194.60% lower compared to the previous year.

The Neurones Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
61.08 EUR
Jan 1, 2019
55.68 EUR
Jan 1, 2020
64.92 EUR
Jan 1, 2021
59.62 EUR
Jan 1, 2022
64.05 EUR
Jan 1, 2023
45.34 EUR
Jan 1, 2024
29.80 EUR
Jan 1, 2025
-28.19 EUR
The Neurones Cash Conversion Cycle history
YEARCash Conversion CycleYoY
-28.19-194.60%
29.80-34.28%
45.34-29.21%
64.05+7.44%
59.62-8.17%
64.92+16.61%
55.68-8.85%
61.08+0.15%
60.99-6.12%
64.97+25.84%
51.63-25.51%
69.31—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neurones Stock analysis

What does Neurones do? Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services. Neurones is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurones stock

Cash Conversion Cycle (CCC) of Neurones is -28.19 in 2025.

Cash Conversion Cycle (CCC) of Neurones changed from 29.80 to -28.19, representing a -194.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Neurones since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Neurones with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Neurones

All Key Metrics — Neurones